In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D

摘要

Aim:There is controversy regarding the potential fitness costs of rifampicin (RIF) resistance-conferring mutations in the Mycobacterium tuberculosis (Mtb) rpoB gene. We characterized the pathogenicity of an Mtb RpoB H526D mutant.